HealthQuill COVID-19
Remember that Covid-19 is still with us, continuously evolving and forming new lineages and we still need to stay ahead of it. Maintaining a cautious vigilance rather than undue panic is the need of the day.
Drugs Health Medical

Neomycin may treat viral respiratory infections, says study

HQ Team April 27, 2024: Viral infections are commonly treated with antivirals. The recent Covid-19 pandemic saw the SARS CoV-2 virus being treated.

Read More
The WHO, health experts and agencies have agreed on the terminology used to describe the spread of a disease through the air after “airborne” and “aerosol transmission” contributed to misleading information during the Covid-19 pandemic.
Drugs Health Pharma

‘Through the air’ is the new terminology for pathogen spread: UN agency

HQ Team April 19, 2024: The WHO, health experts and agencies have agreed on the terminology used to describe the spread of a.

Read More
Humans transmit more viruses in domestic and wild animals than the other way around, scientists found after analyzing 12 million viral genomes from public databases.
Drugs Health Pharma

People spread more virus to animals, not the other way around: Scientists

HQ Team March 27, 2024: Humans transmit more viruses in domestic and wild animals than the other way around, scientists found after analyzing.

Read More
A panel consisting of Nobel laureates, former presidents and prime ministers has urged global negotiators of WHO member states to redouble their efforts to reach a consensus on the Pandemic Accord.
Drugs Health Pharma

Negotiators must close Pandemic Accord talks fast: Global panel

HQ Team March 21, 2024: A panel consisting of Nobel laureates, former presidents and prime ministers have urged global negotiators of WHO member.

Read More
The Covid-19 virus can damage the heart, even without directly affecting the heart tissue, according to a study by the National Institutes of Health (NIH).
Drugs Health Pharma

Severe Covid-19 infection can cause heart damage: NIH study says

HQ Team March 20, 2024: The Covid-19 virus can damage the heart, even without directly affecting the heart tissue, according to a study.

Read More
Lysolipid, a byproduct of the human immune response to viruses and bacteria, may be behind lung instability caused due a life-threatening illness— acute respiratory distress syndrome, researchers said.
Drugs Health Pharma

Excess lysolipids may be main reason for acute respiratory distress syndrome

HQ Team March 13, 2024: Lysolipid, a byproduct of the human immune response to viruses and bacteria, may be behind lung instability caused.

Read More
An 82-year-old German male, who took Covid-19 vaccine 217 times, did not have his immune system weakened but rather strengthened, researchers said.
Drugs Health Pharma

German male injects Covid-19 vaccines 217 times, immunity didn’t weaken

HQ Team March 7, 2024: An 82-year-old German male, who took Covid-19 vaccine 217 times, did not have his immune system weakened but.

Read More
The US Centers for Disease Control and Prevention Control has revised its Covid-19 isolation recommendations by suggesting patients return to normal activities if they are free of fever for at least 24 hours.
Drugs Health Pharma

CDC revises isolation guidance for Covid-19 patients in the US

HQ Team March 2, 2024: The US Centers for Disease Control and Prevention Control has revised its Covid-19 isolation recommendations by suggesting patients.

Read More
About 17,000 people may have died in six countries after using antimalarial drug hydroxychloroquine during the first wave of the Covid-19 pandemic, according to a study.
Drugs Health Pharma

Antimalarial drug may have killed 17,000 people in first Covid-19 wave

HQ Team January 8, 2024: About 17,000 people may have died in six countries after using antimalarial drug hydroxychloroquine during the first wave.

Read More
The prevalence of JN.1, a Covid-19 sub-variant, has risen to 62% in the US on Jan. 5 compared to two weeks prior, according to the National Public Health Agency.
Drugs Health Pharma

JN.1 sub-variant Covid-19 cases rise to 62% in the US, says CDC 

HQ Team January 8, 2023: The prevalence of JN.1, a Covid-19 sub-variant, has risen to 62% in the US on Jan. 5 compared.

Read More
X